Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuradh Joseph

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 18, 2021
Optimizing Organ Preservation Strategies in Localized Muscle Invasive Bladder CancerNuradh Joseph
The Lancet. Oncology|May 3, 2019
SABR versus conventional fractionation regimens in NSCLCNuradh Joseph, Ananya Choudhury
South Asian Journal of Cancer|February 28, 2023
Cervical Cancer in Sri LankaAhamed Iqbal, Nuradh Joseph
European Urology Focus|July 21, 2017
Fit Patient with Nonmetastatic Castration-resistant Prostate Cancer, Lower Urinary Tract Symptoms, and Severe Recurrent HaematuriaNuradh Joseph, Ananya Choudhury
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2021
Dosimetric Predictors of Radiotherapy-Induced Lymphocytopenia in Lung CancerNuradh Joseph, Ananya Choudhury
International Journal of Radiation Oncology, Biology, Physics|September 30, 2016
Adjuvant Chemotherapy Is More Suitable Than Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer Patients Treated With Radical ChemoradiotherapyNuradh Joseph, Ananya Choudhury
Cancer Journal (Sudbury, Mass.)|January 25, 2020
Treatment of Primary in Metastatic Prostate Cancer: What Is the Standard of Care?Nuradh Joseph, Milan Anjanappa, Ananya Choudhury
Advances in Clinical Chemistry|March 26, 2022
Biomarkers in muscle invasive bladder cancerFiona Wilson, Nuradh Joseph, Ananya Choudhury
Seminars in Radiation Oncology|December 14, 2022
Myths About Bladder Preservation in Muscle-Invasive Bladder CancerThiraviyam Elumalai, Nuradh Joseph, Ananya Choudhury
BMJ Oncology|June 29, 2026
Cost-effectiveness of neoadjuvant and adjuvant novel cancer therapies in stage II-III non-small cell lung cancer in Sri LankaNuradh Joseph, Sanjeewa Kularatna, Sameera Senanayake
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|November 18, 2021
Optimizing Organ Preservation Strategies in Localized Muscle Invasive Bladder CancerNuradh Joseph
The Lancet. Oncology|May 3, 2019
SABR versus conventional fractionation regimens in NSCLCNuradh Joseph, Ananya Choudhury
South Asian Journal of Cancer|February 28, 2023
Cervical Cancer in Sri LankaAhamed Iqbal, Nuradh Joseph
European Urology Focus|July 21, 2017
Fit Patient with Nonmetastatic Castration-resistant Prostate Cancer, Lower Urinary Tract Symptoms, and Severe Recurrent HaematuriaNuradh Joseph, Ananya Choudhury
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2021
Dosimetric Predictors of Radiotherapy-Induced Lymphocytopenia in Lung CancerNuradh Joseph, Ananya Choudhury
International Journal of Radiation Oncology, Biology, Physics|September 30, 2016
Adjuvant Chemotherapy Is More Suitable Than Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer Patients Treated With Radical ChemoradiotherapyNuradh Joseph, Ananya Choudhury
Cancer Journal (Sudbury, Mass.)|January 25, 2020
Treatment of Primary in Metastatic Prostate Cancer: What Is the Standard of Care?Nuradh Joseph, Milan Anjanappa, Ananya Choudhury
Advances in Clinical Chemistry|March 26, 2022
Biomarkers in muscle invasive bladder cancerFiona Wilson, Nuradh Joseph, Ananya Choudhury
Seminars in Radiation Oncology|December 14, 2022
Myths About Bladder Preservation in Muscle-Invasive Bladder CancerThiraviyam Elumalai, Nuradh Joseph, Ananya Choudhury
BMJ Oncology|June 29, 2026
Cost-effectiveness of neoadjuvant and adjuvant novel cancer therapies in stage II-III non-small cell lung cancer in Sri LankaNuradh Joseph, Sanjeewa Kularatna, Sameera Senanayake
Pageof 3